Update on epinephrine (adrenaline) for pediatric emergencies

Current Opinion in Pediatrics

Volumn 21, Issue 3, 2009, Pages 313-319

  Walker, David M ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenaline; Anaphylaxis; Croup; Epinephrine; Epinephrine autoinjector

Indexed keywords

ADRENALIN; IPRATROPIUM BROMIDE; LEVALBUTEROL; SALBUTAMOL;

ANAPHYLAXIS; ASTHMA; BRONCHIOLITIS; CROUP; DEVICE; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG HALF LIFE; DRUG TOLERABILITY; ELECTROCARDIOGRAM; EMERGENCY CARE; FINGER TIP INJURY; HEART RATE; HUMAN; HYPOTENSION; LOCAL ANESTHESIA; NAUSEA; NOSE DISEASE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; SELF INJECTION; SIDE EFFECT; SUPRAVENTRICULAR TACHYCARDIA; THORAX PAIN; TREMOR; VASTUS LATERALIS MUSCLE;

ADRENERGIC AGONISTS; ANAPHYLAXIS; ASTHMA; BRONCHIOLITIS; CHILD; CROUP; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION ROUTES; EMERGENCIES; EPINEPHRINE; HUMANS; INJECTIONS; INTENSIVE CARE UNITS, PEDIATRIC; TREATMENT OUTCOME;

EID: 67651120040     PISSN: 10408703     EISSN: None     Source Type: Journal    
DOI: 10.1097/MOP.0b013e32832b1067     Document Type: Review

References (50)

1. Davenport HW. Epinephrin(e). Physiologist 1982; 25:76-82.
2. Beck R, Elias N, Shoval S, et al. Computerized acoustic assessment of treatment efficacy of nebulized epinephrine and albuterol in RSV bronchiolitis. BMC Pediatr 2007; 7:22. (Pubitemid 47019324)
3. Zorc JJ. Bronchiolitis trial and tribulation. Acad Emerg Med 2008; 15:375-376. A brief discussion of the controversies surrounding the treatment of bronchiolitis, which includes the author's thoughts on nebulized epinephrine.
4. Scarfone RJ. Controversies in the treatment of bronchiolitis. Curr Opin Pediatr 2005; 17:62-66.
5. Ralston S, Hartenberger C, Anaya T, et al. Randomized, placebo-controlled trial of albuterol and epinephrine at equipotent beta-2 agonist doses in acute bronchiolitis. Pediatr Pulmonol 2005; 40:292-299. (Pubitemid 41437605)
6. Langley JM, Smith MB, LeBlanc JC, et al. Racemic epinephrine compared to salbutamol in hospitalized young children with bronchiolitis; a randomized controlled clinical trial [ISRCTN46561076]. BMC Pediatr 2005; 5:7.
7. Walsh P, Caldwell J, McQuillan KK, et al. Comparison of nebulized epinephrine to albuterol in bronchiolitis. Acad Emerg Med 2008; 15:305-313. This is the most recent randomized controlled trial that evaluates albuterol versus nebulized epinephrine in 703 patients with bronchiolitis. Nonadjusted results showed no difference between the agents in terms of discharge and admission rates and adverse effects. When results were adjusted for severity, the authors found a lower risk for admission (aRR=0.88) with albuterol.
8. Hartling L, Wiebe N, Russell K, et al. A meta-analysis of randomized controlled trials evaluating the efficacy of epinephrine for the treatment of acute viral bronchiolitis. Arch Pediatr Adolesc Med 2003; 157:957-964. (Pubitemid 37222090)
9. Waseem M. Use of racemic epinephrine in bronchiolitis: what is the emergency physician's perspective? Chest 2006; 129:1114-1115.
10. Plint AC, Johnson DW, Wiebe N, et al. Practice variation among pediatric emergency departments in the treatment of bronchiolitis. Acad Emerg Med 2004; 11:353-360. (Pubitemid 38437010)
11. Klig JE. Office pediatrics: current perspectives on the outpatient evaluation and management of lower respiratory infections in children. Curr Opin Pediatr 2006; 18:71-76.
12. Rodrigo GJ, Nannini LJ. Comparison between nebulized adrenaline and beta2 agonists for the treatment of acute asthma. A meta-analysis of randomized trials. Am J Emerg Med 2006; 24:217-222.
13. Plint AC, Osmond MH, Klassen TP. The efficacy of nebulized racemic epinephrine in children with acute asthma: a randomized, double-blind trial. Acad Emerg Med 2000; 7:1097-1103.
14. Wiebe K, Rowe BH. Nebulized racemic epinephrine used in the treatment of severe asthmatic exacerbation: a case report and literature review. CJEM 2007; 9:304-308. (Pubitemid 47232901)
15. Smith D, Riel J, Tilles I, et al. Intravenous epinephrine in life-threatening asthma. Ann Emerg Med 2003; 41:706-711.
16. Putland M, Kerr D, Kelly AM. Adverse events associated with the use of intravenous epinephrine in emergency department patients presenting with severe asthma. Ann Emerg Med 2006; 47:559-563. (Pubitemid 43732513)
17. Green SM. Intravenous epinephrine in asthma? A word of caution. Ann Emerg Med 2003; 41:712-713. (Pubitemid 36520252)
18. Stannard W, O'Callaghan C. Management of croup. Pediatr Drugs 2002; 4:231-240.
19. Cherry JD. Clinical practice. Croup. N Engl J Med 2008; 358:384-391.
20. Bjornson CL, Johnson DW. Croup. Lancet 2008; 371:329-339. A comprehensive review of the presentation and management of croup. It includes a treatment algorithm and a discussion on the evidence behind the use of epinephrine for this illness.
21. Bjornson CL, Johnson DW. Croup in the paediatric emergency department. Paediatr Child Health 2007; 12:473-477.
22. Waisman Y, Klein BL, Boenning DA, et al. Prospective randomized double-blind study comparing L-epinephrine and racemic epinephrine aerosols in the treatment of laryngotracheitis (croup). Pediatrics 1992; 89:302-306.
23. Teksam O. Can the proposed dose of epinephrine for severe crou changed? J Emerg Med 2008. [Epub ahead of print] In a brief letter to the editor, Teksam suggests that currently recommended dosing of nebulized epinephrine for croup may not be appropriate.
24. Johnson D, Bjornson C, Durec T, et al. Nebulized epinephrine for croup in children. Cochrane Database Syst Rev CD006619. doi: 10.1002/14651858.
25. Borland ML, Babl FE, Sheriff N, Esson AD. Croup management in Australia and New Zealand: a PREDICT study of physician practice and clinical practice guidelines. Pediatr Emerg Care 2008; 24:452-456. The authors present a study analyzing physicians' adherence to their own institution's clinical practice guidelines for croup. There is a brief discussion isolating the use of epinephrine.
26. Liberman DB, Teach SJ. Management of anaphylaxis in children. Pediatr Emerg Care 2008; 24:861-866. Liberman and Teach provide a comprehensive, yet succinct review applicable to a wide audience. They include a discussion of the issues surrounding the use of epinephrine.
27. Simons FE. Emergency treatment of anaphylaxis. BMJ 2008; 336:1141-1142.
28. Tse Y, Rylance G. Emergency management of anaphylaxis in children and young people: new guidance from the Resuscitation Council (UK). Arch Dis Child 2008. [Epub ahead of print]
29. de Silva IL, Mehr SS, Tey D, Tang ML. Paediatric anaphylaxis: a 5 year retrospective review. Allergy 2008; 63:1071-1076.
30. Kemp SF, Lockey RF, Simons FE, World Allergy Organization ad hoc Committee on Epinephrine in Anaphylaxis. Epinephrine: the drug of choice for anaphylaxis. A statement of the World Allergy Organization. Allergy 2008; 63:1061-1070. This publication provides an in-depth discussion of epinephrine as it applies to the management of anaphylaxis. The authors touch on the pharmacology of epinephrine, the controversies of autoinjectors and healthcare professional adherence to management recommendations.
31. Soar J, Pumphrey R, Cant A, et al., Working Group of the Resuscitation Council (UK). Emergency treatment of anaphylactic reactions - guidelines for healthcare providers. Resuscitation 2008; 77:157-169. This article contains brief discussions on UK guidelines for the use of i.m. and i.v. epinephrine in anaphylaxis. They provide dosing based on age, rather than weight.
32. Martelli A, Ghiglioni D, Sarratud T, et al. Anaphylaxis in the emergency department: a paediatric perspective. Curr Opin Allergy Clin Immunol 2008; 8:321-329. This is a review from Italy on anaphylaxis in the pediatric ED. The authors include discussions on biphasic anaphylaxis and provide a treatment algorithm.
33. Kemp SF. The postanaphylaxis dilemma: how long is long enough to observe a patient after resolution of symptoms? Curr Allergy Asthma Rep 2008; 8:45-48. Kemp provides an excellent discussion of biphasic anaphylaxis and the evidence behind observation after treatment of anaphylaxis.
34. Tole JW, Lieberman P. Biphasic anaphylaxis: review of incidence, clinical predictors, and observation recommendations. Immunol Allergy Clin North Am 2007; 27:309-326. (Pubitemid 46686990)
35. Simons FE, Roberts JR, Gu X, Simons KJ. Epinephrine absorption in children with a history of anaphylaxis. J Allergy Clin Immunol 1998; 101 (1 Pt 1):33-37. This is a sentinel study that provides the evidence for superiority of i.m. over subcutaneous administration of epinephrine in children. (Pubitemid 28112878)
36. Simons FE, Gu X, Simons KJ. Epinephrine absorption in adults: intramuscular versus subcutaneous injection. J Allergy Clin Immunol 2001; 108:871-873. (Pubitemid 33096224)
37. Sicherer SH, Simons FE, Section on Allergy and Immunology, American Academy of Pediatrics. Self-injectable epinephrine for first-aid management of anaphylaxis. Pediatrics 2007; 119:638-646.
38. Haymore BR, Carr WW, Frank WT. Anaphylaxis and epinephrine prescribing patterns in a military hospital: underutilization of the intramuscular route. Allergy Asthma Proc 2005; 26:361-365.
39. Alexander R, Pappachan R, Smith GB, Taylor BL. Treatment of acute anaphylaxis. Avoid subcutaneous or intramuscular adrenaline. BMJ 1995; 311: 1434-1435.
40. Schlegel C, Fux R, Biedermann T. Epinephrine inhalers in emergency sets of patients with anaphylaxis. J Dtsch Dermatol Ges 2008. [Epub ahead of print] This article discusses epinephrine inhalers and their potential role in the treatment of patients with anaphylaxis.
41. Rawas-Qalaji MM, Simons FE, Simons KJ. Sublingual epinephrine tablets versus intramuscular injection of epinephrine: dose equivalence for potential treatment of anaphylaxis. J Allergy Clin Immunol 2006; 117:398-403.
42. Pumphrey RSH. When should self-injectable epinephrine be prescribed for food allergy and when should it be used? Curr Opin Allergy Clin Immunol 2008; 8:254-260. A comprehensive review of epinephrine autoinjectors and the issues and controversies surrounding their use for anaphylaxis. The author includes pictures that highlight the potential for accidental subcutaneous injection in those with adipose in the lateral thigh thicker than the length of the needle.
43. Arkwright PD. Automatic epinephrine device use in children with food allergies. J Allergy Clin Immunol 2009; 123:267-268.
44. Davis JE. Self-injectable epinephrine for allergic emergencies. J Emerg Med 2008. [Epub ahead of print] This article reviews indications and appropriate techniques for the administration of an epinephrine autoinjector, complete with step-by-step directions and illustrations.
45. Järvinen KM, Sicherer SH, Sampson HA, Nowak-Wegrzyn A. Use of multiple doses of epinephrine in food-induced anaphylaxis in children. J Allergy Clin Immunol 2008; 122:133-138. The authors identified asthma as a risk factor for repeated doses of epinephrine in food-induced anaphylaxis. This finding suggests that asthmatic patients may need to carry more than one autoinjector at a time.
46. Body R. Best BETs from the Manchester Royal Infirmary. Bet 1. Epinephrine self-injection for anaphylaxis in children. Emerg Med J 2008; 25:163-165. A literature review that serves to investigate whether or not autoinjectors lead to reduced morbidity and mortality in children with anaphylaxis.
47. Fitzcharles-Bowe C, Denkler K, Lalonde D. Finger injection with high-dose (1:1,000) epinephrine: does it cause finger necrosis and should it be treated? Hand (NY) 2007; 2:5-11.
48. Carlson DW, Digulio GA, Givens TG, et al. Illustrated techniques of pediatric emergency procedures. In: Fleisher GR, Ludwig S, Henretig FM, editors. Textbook of pediatric emergency medicine. 5th ed. Philadelphia: Lippincott Williams & Wilkins; 2006. p. 1937.
49. Thomson CJ, Lalonde DH, Denkler KA, Feicht AJ. A critical look at the evidence for and against elective epinephrine use in the finger. Plast Reconstr Surg 2007; 119:260-266.
50. Mohan PP. Towards evidence based emergency medicine: best BETs from the Manchester Royal Infirmary. Epinephrine in digital nerve block. Emerg Med J 2007; 24:789-790.